If you read the two papers from last year, you can not come away unimpressed. The Scientific Reports paper (2018) 8:12538 deserved to have been published in an even better journal, especially when one considers the data in Figure 7. To recap, it shows CPP mediated delivery of a PMO therapeutic in an in vivo disease model of DMD. For those of you who don’t live and die by biology jargon, the paper showed that CPPs can deliver a PMO into a mouse tissue with a good degree of efficacy, and that the PMO then fixes the disease. And so yes, I am positive about the technology - it works. It's a credit to the team.
If you read the two papers from last year, you can not come away...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |